Home | News | Find a Doctor | Ask a Question | Free

Minoxidil may suppress androgen receptor


Minoxidil may suppress androgen receptor-related functions.

AuthorsHsu CL, et al. Show all Journal
Oncotarget. 2014 Apr 8. [Epub ahead of print]

Although minoxidil has been used for more than two decades to treat androgenetic alopecia (AGA), an androgen-androgen receptor (AR) pathway-dominant disease, its precise mechanism of action remains elusive. We hypothesized that minoxidil may influence the AR or its downstream signaling. These tests revealed that minoxidil suppressed AR-related functions, decreasing AR transcriptional activity in reporter assays, reducing expression of AR targets at the protein level, and suppressing AR-positive LNCaP cell growth. Dissecting the underlying mechanisms, we found that minoxidil interfered with AR-peptide, AR-coregulator, and AR N/C-terminal interactions, as well as AR protein stability. Furthermore, a crystallographic analysis using the AR ligand-binding domain (LBD) revealed direct binding of minoxidil to the AR in a minoxidil-AR-LBD co-crystal model, and surface plasmon resonance assays demonstrated that minoxidil directly bound the AR with a Kd value of 2.6 µM. Minoxidil also suppressed AR-responsive reporter activity and decreased AR protein stability in human hair dermal papilla cells. The current findings provide evidence that minoxidil could be used to treat both cancer and age-related disease, and open a new avenue for applications of minoxidil in treating androgen-AR pathway-related diseases.

PMID 24742982 [PubMed - as supplied by publisher]
Free full text: Impact Journals, LLC
Citation 4 of 16594


interesting find… once the mechanisms of minoxidil are fully understood, perhaps a more efficient and targeted version can be developed


Does anyone know what type of cancer will minoxidil prevent?